+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Anaphylaxis Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Medication Type, Route of Administration, Allergy Type and Distribution Channel

  • PDF Icon

    Report

  • 154 Pages
  • July 2021
  • Region: Asia Pacific
  • The Insight Partners
  • ID: 5416337
Epinephrine Segment has the Largest Share of Medication Type in the Asia Pacific Anaphylaxis Treatment Market during 2021-2028

According to a new market research study on “Asia Pacific Anaphylaxis Treatment Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Medication Type, Route of Administration, Allergy Type, and Distribution Channel,” is expected to reach US$ 664.0 million by 2028 from US$ 350.7 million in 2021. The market is estimated to grow at a CAGR of 9.6% from 2021 to 2028. The report provides trends prevailing in the Asia Pacific anaphylaxis treatment market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the rising incidence of anaphylaxis and recent approvals of epinephrine are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the poor accessibility to epinephrine auto-injectors in low-income countries.

Certainly, COVID-19 increases the risk of aggravating asthma and allergic diseases, but the government and private agencies are guiding for the treatments. According to guidelines of the Korean Academy of Asthma, Allergy and Clinical Immunology, and the Korean Academy of Pediatric Allergy and Respiratory Disease, detailed monitoring and optimal treatment with AIT, ICS, and biologics need to be continued in all patients who have asthma and allergic diseases. This can be achieved in a safe condition using optimal protective measures. Patients at high risk (older age and comorbid conditions) should be monitored more strictly. All the allergy/immunology specialists who strive to stay up for optimal health protection by focusing on patient management during the COVID-19 pandemic are necessary. As APAC passes through these challenging times of the COVID-19 pandemic, The Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) as an allergy/immunology community via its COVID-19 Task Force is carefully monitoring and updating Food and Drug Administration/Centers for Disease Control and Prevention/ WHO and other crucial scientific information on COVID-19 on its website COVID-19 resource section. Thus, the rising need for allergy treatment is likely to boost the market.

The market for anaphylaxis treatment market is segmented into medication type, route of administration, allergy type, and distribution channel. Based on medication type, the anaphylaxis treatment market is segmented epinephrine, antihistamines, steroids, beta-agonist, and others. In 2020, epinephrine segment accounted for the highest share of the market. The growth of the epinephrine is attributed due to easy access to the epinephrine, rising incidences of allergic reactions and growing government policies to access epinephrine to school-going children. Additionally, the rise in the number of a product launch for generic version epinephrine is key factor responsible for the growth of the market. For instance, in July 2019, Sandoz, a Novartis AG division, has launched its generic pre-filled Symjepi epinephrine shots across the country.

Amneal Pharmaceuticals Inc. Mylan N.V. Abbott, Pfizer Inc. Glaxosmithkline Plc. Merck and Co. Inc. Teva Pharmaceutical Industries Ltd. and ALK-ABELLó are among the leading companies in the Asia Pacific anaphylaxis treatment market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in December 2020, GSK Consumer Healthcare launched Otrivin Breathe clean, a saline wash with the moisturizing benefit of natural glycerin. The daily usage of the nasal spray washes out the allergens, pollutants, and debris that are trapped in the nasal passage, helping in the removal of allergy symptoms, and thus maintaining nasal hygiene.

The report segments the Asia Pacific Anaphylaxis Treatment market as follows:


By Medication Type

  • Epinephrine
  • Antihistamines
  • Steroids
  • Beta-Agonist
  • Others

By Route of Administration

  • Parenteral
  • Oral
  • Others

By Allergy Type

  • Food Allergy
  • Medications
  • Insect Stings
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

By Country

  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific

Reasons to buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific anaphylaxis treatment market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific anaphylaxis treatment market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the anaphylaxis treatment market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Anaphylaxis Treatment Market - By Medication Type
1.3.2 Anaphylaxis Treatment Market - By Route of Administration
1.3.3 Anaphylaxis Treatment Market - By Allergy Type
1.3.4 Anaphylaxis Treatment Market - By Distribution Channel
1.3.5 Asia Pacific Anaphylaxis Treatment Market - By Country
2. Asia Pacific Anaphylaxis Treatment Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Anaphylaxis Treatment Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Anaphylaxis Treatment Market - Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Anaphylaxis Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Anaphylaxis
5.1.2 Recent Approvals for Epinephrine
5.2 Market Restraints
5.2.1 Poor Access to Epinephrine Auto-Injectors in Low-Income Countries
5.3 Market Opportunities
5.3.1 Rise in Cases of Allergies Post Administration of COVID-19 Vaccines
5.4 Future Trends
5.4.1 Novel Drug Delivery Systems
5.5 Impact Analysis
6. Anaphylaxis Treatment Market - Asia Pacific Analysis
6.1 Asia Pacific Anaphylaxis Treatment Market Revenue Forecasts and Analysis
7. Asia Pacific Anaphylaxis Treatment Market Analysis and Forecasts To 2028 - By Medication Type
7.1 Overview
7.2 Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)
7.3 Epinephrine
7.3.1 Overview
7.3.2 Epinephrine: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Antihistamines
7.4.1 Overview
7.4.2 Antihistamines: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Steroids
7.5.1 Overview
7.5.2 Steroids: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Beta-Agonist
7.6.1 Overview
7.6.2 Beta-Agonist: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
8. Anaphylaxis Treatment Market Analysis - By Route of Administration
8.1 Overview
8.2 Anaphylaxis Treatment Market Revenue Share, by Route of Administration (2020 and 2028)
8.3 Oral
8.3.1 Overview
8.3.2 Oral: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Parenteral
8.4.1 Overview
8.4.2 Parenteral: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Anaphylaxis Treatment Market Analysis and Forecasts To 2028 - By Allergy Type
9.1 Overview
9.2 Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028, (%)
9.3 Food Allergy
9.3.1 Overview
9.3.2 Food Allergy: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Medications
9.4.1 Overview
9.4.2 Medications: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Insect Stings
9.5.1 Overview
9.5.2 Insect Stings: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Anaphylaxis Treatment Market Analysis and Forecasts to 2028 - By Distribution Channel
10.1 Overview
10.2 Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)
10.3 Retail Sales
10.3.1 Overview
10.3.2 Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
10.4 Hospital Pharmacies
10.4.1 Overview
10.4.2 Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
10.5 Others
10.5.1 Overview
10.5.2 Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)
11. Anaphylaxis Treatment Market Revenue and Forecasts to 2028 - Geographical Analysis
11.1 Asia Pacific: Anaphylaxis Treatment Market
11.1.1 Overview
11.1.2 Asia Pacific: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
11.1.2.1 Japan: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.1 Japan: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.2 Japan: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.1.2.1.3 Japan: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.2.1.4 Japan: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.2.1.5 Japan: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.1.2.1.6 Japan: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.1.2.2 China: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1 China: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.2 China: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.1.2.2.3 China: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.2.2.4 China: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.2.2.5 China: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.1.2.2.6 China: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.1.2.3 India: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.1 India: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.2 India: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.1.2.3.3 India: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.2.3.4 India: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.2.3.5 India: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.1.2.3.6 India: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.1.2.4 South Korea: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.4.1 South Korea: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.4.2 South Korea: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.1.2.4.3 South Korea: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.2.4.4 South Korea: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.2.4.5 South Korea: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.1.2.4.6 South Korea: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.1.2.5 Australia: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.5.1 Australia: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.5.2 Australia: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.1.2.5.3 Australia: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.2.5.4 Australia: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.2.5.5 Australia: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.1.2.5.6 Australia: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.1.2.6 Rest of Asia Pacific: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.6.1 Rest of Asia Pacific: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.6.2 Rest of Asia Pacific: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.1.2.6.3 Rest of Asia Pacific: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.2.6.4 Rest of Asia Pacific: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.2.6.5 Rest of Asia Pacific: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.1.2.6.6 Rest of Asia Pacific: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Asia Pacific Anaphylaxis Treatment Market
12.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. COMPANY PROFILES
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 ALK-Abelló A/S
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Amneal Pharmaceuticals, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline plc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Merck & Co., Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 MYLAN N.V.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Pfizer Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 TEVA PHARMACEUTICAL INDUSTRIES LTD
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
15. Appendix
15.1 About
15.2 Glossary of Terms
List of Tables
Table 1. Japan: Anaphylaxis Treatment Market, by Medication Type - Revenue and Forecast to 2028 (USD Million)
Table 2. Japan: Epinephrine Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 3. Japan: Others Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 4. Japan: Anaphylaxis Treatment Market, by Allergy Type - Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Anaphylaxis Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 6. China: Anaphylaxis Treatment Market, by Medication Type - Revenue and Forecast to 2028 (USD Million)
Table 7. China: Epinephrine Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 8. China: Others Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 9. China: Anaphylaxis Treatment Market, by Allergy Type - Revenue and Forecast to 2028 (USD Million)
Table 10. China: Anaphylaxis Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 11. India: Anaphylaxis Treatment Market, by Medication Type - Revenue and Forecast to 2028 (USD Million)
Table 12. India: Epinephrine Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 13. India: Others Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 14. India: Anaphylaxis Treatment Market, by Allergy Type - Revenue and Forecast to 2028 (USD Million)
Table 15. India: Anaphylaxis Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 16. South Korea: Anaphylaxis Treatment Market, by Medication Type - Revenue and Forecast to 2028 (USD Million)
Table 17. South Korea: Epinephrine Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 18. South Korea: Others Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea: Anaphylaxis Treatment Market, by Allergy Type - Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea: Anaphylaxis Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 21. Australia: Anaphylaxis Treatment Market, by Medication Type - Revenue and Forecast to 2028 (USD Million)
Table 22. Australia: Epinephrine Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 23. Australia: Others Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 24. Australia: Anaphylaxis Treatment Market, by Allergy Type - Revenue and Forecast to 2028 (USD Million)
Table 25. Australia: Anaphylaxis Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 26. Rest of Asia Pacific: Anaphylaxis Treatment Market, by Medication Type - Revenue and Forecast to 2028 (USD Million)
Table 27. Rest of Asia Pacific: Epinephrine Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 28. Rest of Asia Pacific: Others Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 29. Rest of Asia Pacific: Anaphylaxis Treatment Market, by Allergy Type - Revenue and Forecast to 2028 (USD Million)
Table 30. Rest of Asia Pacific: Anaphylaxis Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 31. Organic Developments Done by Companies
Table 32. Inorganic Developments Done by Companies
Table 33. Glossary of Terms, Anaphylaxis Treatment Market
List of Figures
Figure 1. Anaphylaxis Treatment Market Segmentation
Figure 2. Asia Pacific Anaphylaxis Treatment Market Overview
Figure 3. Epinephrine Segment Held Largest Share of Medication Type in Anaphylaxis Treatment Market
Figure 4. Japan is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Anaphylaxis Treatment Market - Asia Pacific PEST Analysis
Figure 6. Anaphylaxis Treatment Market Impact Analysis of Driver and Restraints
Figure 7. Asia Pacific Anaphylaxis Treatment Market - Revenue Forecasts and Analysis - 2020 - 2028
Figure 8. Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)
Figure 9. Epinephrine: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 10. Antihistamines: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. Steroids: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Beta-Agonist: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Anaphylaxis Treatment Market Revenue Share, Route of Administration (2020 and 2028)
Figure 15. Oral: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Parenteral: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Others: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028 (%)
Figure 19. Food Allergy: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Medications: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Insect Stings: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)
Figure 24. Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 25. Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 26. Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)
Figure 27. Asia Pacific: Anaphylaxis Treatment Market, by Key Country - Revenue (2020) (USD Million)
Figure 28. Asia Pacific: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
Figure 29. Japan: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 30. China: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 31. India: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 32. South Korea: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 33. Australia: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 34. Rest of Asia Pacific: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 36. Growth Strategies Done by the Companies in the Market, (%)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Amneal Pharmaceuticals Inc.
  • Mylan N.V.
  • Abbott
  • Pfizer Inc.
  • Glaxosmithkline Plc.,
  • Merck And Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • ALK-ABELLó

Table Information